Zai Lab (ZLAB) Capital Expenditures (2020 - 2026)
Zai Lab's (ZLAB) quarterly Capital Expenditures came in at $1.2 million in Q1 2026, down 22.1% year-on-year from $1.5 million in Q1 2025, and up 76.51% quarter-over-quarter from $677000.0 in Q4 2025.
Zai Lab (ZLAB) Capital Expenditures (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Capital Expenditures across 7 years of filings, most recently posting $1.2 million for Q1 2026.
- Capital Expenditures for Q1 2026 came in at $1.2 million, down 22.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.8 million (up 24.85% YoY), and the FY2025 annual result was $8.1 million, up 43.2% from the prior year.
- Capital Expenditures came in at $1.2 million for Q1 2026 at Zai Lab, up from $677000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $9.7 million in Q1 2022 to a low of $222000.0 in Q4 2023.
- The 5-year median for Capital Expenditures is $1.8 million (2023), against an average of $2.8 million.
- Across the five-year window, Capital Expenditures plunged 94.97% in 2023 and jumped 1071.17% in 2024, its largest moves.
- Zai Lab's Capital Expenditures stood at $4.4 million in 2022, then slumped by 94.97% to $222000.0 in 2023, then surged by 1071.17% to $2.6 million in 2024, then tumbled by 73.96% to $677000.0 in 2025, then soared by 76.51% to $1.2 million in 2026.
- The last three Capital Expenditures figures came in at $1.2 million (Q1 2026), $677000.0 (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 677,000.00 |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 3.01 Mn |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 741,000.00 |
| Jun 30, 2024 | 741,000.00 |
| Mar 31, 2024 | 974,000.00 |
| Mar 31, 2024 | 974,000.00 |
| Dec 31, 2023 | 222,000.00 |
| Dec 31, 2023 | 222,000.00 |